Altered Hematopoiesis, Behavior, and Sexual Function in μ Opioid Receptor–deficient Mice
Mingting Tian(Indiana University School of Medicine), Lei Yu(Rutgers, The State University of New Jersey), Robert M. Bigsby(Indiana University School of Medicine), Heiko T. Jansen(Indiana University School of Medicine), Moyin Ying(Indiana University School of Medicine), Hal E. Broxmeyer(Indiana University School of Medicine), Susan M. Aronica(University of Illinois Urbana-Champaign), Sandra J. Engle(Pfizer (United States)), Michael N. Lehman(University of Mississippi Medical Center), Anton Mestek(Indiana University School of Medicine), Shengwen Zhang(Indiana University School of Medicine), Jonathan D. Pollock(Indiana University School of Medicine), Rosemary Steinmetz(Indiana University – Purdue University Indianapolis), Scott Cooper(Indiana University School of Medicine), Zhennan Lai(Indiana University School of Medicine), Yi Fan(Indiana University School of Medicine), Peter J. Stambrook(Indiana University School of Medicine), Jay A. Tischfield(Indiana University School of Medicine)
Cited by 171
Related Papers
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
|The Journal of Experimental Medicine|2005|1.1k
Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
|Proceedings of the National Academy of Sciences|1998|1.1k
Molecular cloning and functional expression of a mu opioid receptor from rat brain
|Regulatory Peptides|1994|810